Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients.
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. Hata T, et al. Lung Cancer. 2025 Jan 25;200:108104. doi: 10.1016/j.lungcan.2025.108104. Online ahead of print. Lung Cancer. 2025. PMID: 39889466
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. Hata T, et al. Clin Lung Cancer. 2025 Jan 4:S1525-7304(25)00001-4. doi: 10.1016/j.cllc.2025.01.002. Online ahead of print. Clin Lung Cancer. 2025. PMID: 39864962
Thrombin-induced kynurenine 3-monooxygenase causes variations in the kynurenine pathway, leading to neurological deficits in a murine intracerebral hemorrhage model.
Ohnishi M, Banshoya K, Machida A, Kai T, Shimizu Y, Yano Y, Urabe Y, Tasaka S, Furutaguchi M, Shigemasa T, Akagi M, Maehara S, Hata T. Ohnishi M, et al. Among authors: hata t. J Pharmacol Sci. 2025 Feb;157(2):65-74. doi: 10.1016/j.jphs.2024.12.003. Epub 2024 Dec 12. J Pharmacol Sci. 2025. PMID: 39828395 Free article.
The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses.
Sugimoto N, Noura S, Kato T, Yoshioka S, Hata T, Naito A, Tei M, Tamagawa H, Komori T, Ide Y, Fukuzaki T, Danno K, Sawada G, Kagawa Y, Shimokawa T, Miyoshi N, Ogino T, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H. Sugimoto N, et al. Among authors: hata t. Cancers (Basel). 2024 Dec 30;17(1):91. doi: 10.3390/cancers17010091. Cancers (Basel). 2024. PMID: 39796720 Free PMC article.
2,157 results